Medicare Enrolled
Dr. Rachel Kramer, M.D.
Hematology & Oncology · New York, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kramer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kramer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kramer
Dr. Rachel Kramer is a hematology & oncology specialist in New York, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Kramer performed 181,552 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kramer received a total of $17,273 from 93 pharmaceutical and/or device companies across 808 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kramer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 3% volume in NY
$17,273 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗181,552
Medicare services
Top 3% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 59,220 | $8 | $24 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
39,200 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 36,660 | $18 | $112 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
18,870 | $0 | $7 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 12,800 | $38 | $160 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,280 | $22 | $360 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,060 | $6 | $44 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,278 | $0 | $20 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,073 | $50 | $197 |
| Injection, benralizumab, 1 mg | 1,020 | $133 | $320 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
978 | $0 | $6 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
940 | $12 | $78 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
860 | $8 | $30 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
809 | $8 | $87 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
465 | $60 | $343 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
450 | $69 | $381 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
402 | $7 | $450 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
321 | $12 | $64 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
315 | $19 | $102 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
229 | $26 | $148 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
227 | $78 | $321 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
218 | $15 | $79 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
154 | $1 | $4 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
152 | $118 | $676 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $105 | $468 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
103 | $25 | $145 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
71 | $101 | $377 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
57 | $1 | $21 |
| New patient office visit, complex (60-74 min) | 53 | $197 | $712 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
51 | $2 | $38 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
47 | $81 | $491 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
38 | $1 | $18 |
| Heparin sodium injection, per 1000 units An injection of heparin sodium, a blood thinner, administered in units of 1000. |
25 | $0 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $142 | $567 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.0% high complexity
85.0% medium
2.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,273
Total received (2018-2024)
Avg $2,468/year across 7 years
Top 19% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
808
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,268
2023
$2,192
2022
$1,896
2021
$2,428
2020
$1,774
2019
$3,170
2018
$3,544
Payments by company (2024)
PFIZER INC.
$287
Daiichi Sankyo Inc.
$274
GENZYME CORPORATION
$192
Lilly USA, LLC
$122
Agios Pharmaceuticals, Inc.
$107
Amgen Inc.
$106
SOBI, INC
$104
Merck Sharp & Dohme LLC
$95
Celgene Corporation
$89
Regeneron Healthcare Solutions, Inc.
$85
Bayer Healthcare Pharmaceuticals Inc.
$74
Novartis Pharmaceuticals Corporation
$67
Janssen Biotech, Inc.
$64
PharmaEssentia USA Corporation
$58
AstraZeneca Pharmaceuticals LP
$57
Lundbeck LLC
$56
GlaxoSmithKline, LLC.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$52
E.R. Squibb & Sons, L.L.C.
$44
Radius Health, Inc.
$30
EMD Serono, Inc.
$26
Alexion Pharmaceuticals, Inc.
$26
TerSera Therapeutics LLC
$25
Incyte Corporation
$24
Gilead Sciences, Inc.
$23
Aveo Pharmaceuticals, Inc.
$22
ABBVIE INC.
$22
Kyowa Kirin, Inc.
$22
Octapharma USA, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$18
Celltrion USA Inc.
$15
Stemline Therapeutics Inc.
$14
Top 3 companies account for 33.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,515
Janssen Biotech, Inc.
$1,237
AstraZeneca Pharmaceuticals LP
$1,221
Seagen Inc.
$782
Novartis Pharmaceuticals Corporation
$754
Lilly USA, LLC
$667
PFIZER INC.
$648
Daiichi Sankyo Inc.
$625
Merck Sharp & Dohme Corporation
$576
GENZYME CORPORATION
$552
GlaxoSmithKline, LLC.
$531
E.R. Squibb & Sons, L.L.C.
$426
Celgene Corporation
$420
Incyte Corporation
$408
Takeda Pharmaceuticals U.S.A., Inc.
$359
AMAG Pharmaceuticals, Inc.
$353
Rigel Pharmaceuticals, Inc.
$312
Genentech USA, Inc.
$309
Puma Biotechnology, Inc.
$299
Taiho Oncology, Inc.
$296
TerSera Therapeutics LLC
$265
Pharmacyclics LLC, An AbbVie Company
$223
Grifols USA, LLC
$221
Merck Sharp & Dohme LLC
$210
Gilead Sciences, Inc.
$158
Teva Pharmaceuticals USA, Inc.
$155
Clovis Oncology, Inc.
$152
SOBI, INC
$150
Eisai Inc.
$135
Agios Pharmaceuticals, Inc.
$132
Regeneron Healthcare Solutions, Inc.
$129
Bayer HealthCare Pharmaceuticals Inc.
$129
Terumo Medical Corporation
$126
PharmaEssentia USA Corporation
$116
Heron Therapeutics, Inc.
$112
Kyowa Kirin, Inc.
$111
Ipsen Biopharmaceuticals, Inc
$106
Alexion Pharmaceuticals, Inc.
$105
ARRAY BIOPHARMA INC
$99
PUMA BIOTECHNOLOGY, INC.
$91
Sobi, Inc
$83
Lexicon Pharmaceuticals, Inc.
$80
Janssen Pharmaceuticals, Inc
$80
Lundbeck LLC
$78
Horizon Therapeutics plc
$76
Bayer Healthcare Pharmaceuticals Inc.
$74
Biogen, Inc.
$71
Dova Pharmaceuticals
$66
TESARO, Inc.
$62
MEDIVATION FIELD SOLUTIONS LLC
$62
JAZZ PHARMACEUTICALS INC.
$61
Jazz Pharmaceuticals Inc.
$58
Helsinn Therapeutics (U.S.), Inc.
$58
EMD Serono, Inc.
$56
Seattle Genetics, Inc.
$54
Coherus Biosciences Inc.
$53
Advanced Accelerator Applications
$51
Verastem, Inc.
$47
Karyopharm Therapeutics Inc.
$46
SANOFI-AVENTIS U.S. LLC
$46
Global Blood Therapeutics, Inc.
$42
Mitsubishi Tanabe Pharma America, Inc.
$41
EISAI INC.
$40
Amneal Pharmaceuticals LLC
$36
Astellas Pharma US Inc
$34
Radius Health, Inc.
$30
Otsuka America Pharmaceutical, Inc.
$29
Stemline Therapeutics Inc.
$27
Ferring Pharmaceuticals Inc.
$26
Foundation Medicine, Inc.
$26
Cumberland Pharmaceuticals, Inc.
$25
Adaptive Biotechnologies Corporation
$25
Melinta Therapeutics, LLC
$25
TG Therapeutics, Inc.
$25
Secura Bio, Inc.
$25
AbbVie, Inc.
$24
GRT US Holding, Inc.
$23
Myriad Genetic Laboratories, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$23
Dendreon Pharmaceuticals LLC
$23
Aveo Pharmaceuticals, Inc.
$22
ABBVIE INC.
$22
MorphoSys, US Inc.
$21
INSYS Therapeutics Inc
$18
Octapharma USA, Inc.
$18
TG THERAPEUTICS, INC.
$18
AbbVie Inc.
$18
Mylan Institutional Inc.
$17
Emmaus Medical, Inc.
$16
Epizyme, Inc.,
$16
Celltrion USA Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$14
Allergan Inc.
$14
Top 3 companies account for 23.0% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ADUHELM · AFINITOR · AKYNZEO · ALUNBRIG · AVASTIN · Abraxane · Aliqopa · Avastin · BALVERSA · BAVENCIO · BENDEKA · BENLYSTA · BESREMI · BOSULIF · BRAFTOVI · Balversa · CABLIVI · CALDOLOR · CALQUENCE · CINQAIR · CINVANTI · COSENTYX · CYRAMZA · Copiktra · Creon · DALVANCE · DARZALEX · DIFICID · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELOCTATE · ELREXFIO · ENHERTU · ENJAYMO · ENTYVIO · EPKINLY · ERLEADA · EVENITY · Endari · Enhertu · Erleada · FARESTON · FARYDAK · FASENRA · FASLODEX · FERAHEME · FIRMAGON · FOTIVDA · Fabhalta · Fulphila · GAMMAGARD · Gamunex-C · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRYSTEXXA · Kimyrsa · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · NUCALA · Nerlynx · Neulasta · Nplate · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OMVOH · ONTRUZANT · OPDIVO · OPDUALAG · ORENCIA · OXBRYTA · Orserdu · PEMAZYRE · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Pomalyst · Poteligeo · Prolia · QUZYTTIR · Qutenza · Quzyttir · REBLOZYL · REMICADE · RYBREVANT · Radicava · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SAPHNELO · SARCLISA · SCEMBLIX · SIMPONI ARIA · SKYRIZI · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · STELARA · SUSTOL · SUTENT · SYNDROS · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEPEZZA · TUKYSA · TYSABRI · Tavalisse · Tazverik · Trodelvy · Truxima · UBRELVY · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYEPTI · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA · ZINPLAVA · ZOLADEX · ZYKADIA · ZYMFENTRA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
743
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
LENOX HILL HOSPITAL
0.6 mi
0.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kramer is a mixed practice specialist, with above-average Medicare volume (top 3% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kramer experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Kramer performed 59,220 romosozumab injection (evenity) for osteoporosis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kramer receive payments from pharmaceutical companies?
Yes. Dr. Kramer received a total of $17,273 from 93 companies across 808 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kramer's costs compare to other hematology & oncology specialists in New York?
Dr. Kramer's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kramer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in New York
Browse hematology & oncology specialists in New York ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology